Tristan R. Grams
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tristan R. Grams has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- David C. Bloom
Department of Molecular Genetics and Microbiology, University of Florida College of Medicine
6 shared publications Terri G. Edwards
Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, USA
3 shared publications- Blaine A. Mathison
Department of Pathology, University of Utah
2 shared publications - Do Young Kim
Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA
2 shared publications Donald Roseberry
Christus Health, Winnsboro, Texas, USA
2 shared publications- Erin McElvania
Department of Pathology, University of Chicago, Pritzker School of Medicine
2 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e249
Reevaluating the role of fungal blood cultures in clinical practice
In this retrospective study, fungal blood cultures rarely detected fungal pathogens not found in paired standard blood cultures, with added findings in only 0.4% of cases. Given the low diagnostic yield and high cost, results support reserving fungal blood cultures for select high-risk patients to improve diagnostic stewardship.
- 1 September 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e249
Open AccessReevaluating the role of fungal blood cultures in clinical practice
In this retrospective study, fungal blood cultures rarely detected fungal pathogens not found in paired standard blood cultures, with added findings in only 0.4% of cases. Given the low diagnostic yield and high cost, results support reserving fungal blood cultures for select high-risk patients to improve diagnostic stewardship.
- Open Access
- 5 November 2025
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 69 (11) , e0060225
Successful use of olorofim for the treatment of Lomentospora prolificans knee tendonitis, synovitis, and concomitant osteomyelitis in an immunocompetent child
Lomentospora prolificans is a filamentous mold that can cause infections in both immunocompromised and immunocompetent individuals. Infection can be either focal or disseminated, often acquired via inhalation or direct conidia inoculation (A. Konsoula, C. Tsioutis, I. Markaki, M. Papadakis, A.P. Agouridis, N. Spernovasilis. Microorganisms 10:1317, 2022, https://doi.org/10.3390/microorganisms10071317 ). This pathogen is challenging to treat due to its high MICs to available antifungals. We present a case of an 8-year-old previously healthy female who developed L. prolificans knee tendonitis and synovitis with patellar osteomyelitis after a flat patio stone laceration in Southern California, who ultimately was treated with the novel antifungal, olorofim.
- 5 November 2025
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 69 (11) , e0060225
Open AccessSuccessful use of olorofim for the treatment of Lomentospora prolificans knee tendonitis, synovitis, and concomitant osteomyelitis in an immunocompetent child
Lomentospora prolificans is a filamentous mold that can cause infections in both immunocompromised and immunocompetent individuals. Infection can be either focal or disseminated, often acquired via inhalation or direct conidia inoculation (A. Konsoula, C. Tsioutis, I. Markaki, M. Papadakis, A.P. Agouridis, N. Spernovasilis. Microorganisms 10:1317, 2022, https://doi.org/10.3390/microorganisms10071317 ). This pathogen is challenging to treat due to its high MICs to available antifungals. We present a case of an 8-year-old previously healthy female who developed L. prolificans knee tendonitis and synovitis with patellar osteomyelitis after a flat patio stone laceration in Southern California, who ultimately was treated with the novel antifungal, olorofim.
- 13 March 2024
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 62 (3) , e0126023
Photo Quiz: An ear-resistible occupant in a 73-year-old patient
- 13 March 2024
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 62 (3) , e0126023
Photo Quiz: An ear-resistible occupant in a 73-year-old patient
- 13 March 2024
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 62 (3) , e0126123
Answer to March 2024 Photo Quiz
Read the full article for the answer.
- 13 March 2024
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 62 (3) , e0126123
Answer to March 2024 Photo Quiz
Read the full article for the answer.
- 21 December 2023
- Published by American Society for Microbiology in Journal of Virology
- Vol. 97 (12) , e0143823
A viral lncRNA tethers HSV-1 genomes at the nuclear periphery to establish viral latency
Herpes simplex virus 1 (HSV-1) produces a long noncoding RNA, the latency-associated transcript (LAT), that mediates silencing of the virus in neurons through unknown mechanisms. Here, we show that the LAT binds both the cellular transmembrane protein 43 (TMEM43) and HSV-1 genomes in human neurons. Additionally, loss of TMEM43 prior to infection results in a decreased ability of the virus to establish latency, mirroring phenotypes of LAT promoter mutant viruses which are also defective in establishing latency. These data support a unique mechanism whereby the LAT binds TMEM43 and the HSV genome to localize HSV-1 genomes to the nuclear periphery to repress lytic viral transcription and establish viral latency and suggests that TMEM43 may play a similar role in regulating cellular genes. IMPORTANCE: Herpes simplex virus 1 (HSV-1) establishes lifelong latency in neuronal cells. Following a stressor, the virus reactivates from latency, virus is shed at the periphery and recurrent disease can occur. During latency, the viral lncRNA termed the latency-associated transcript (LAT) is known to accumulate to high abundance. The LAT is known to impact many aspects of latency though the molecular events involved are not well understood. Here, we utilized a human neuronal cell line model of HSV latency and reactivation (LUHMES) to identify the molecular-binding partners of the LAT during latency. We found that the LAT binds to both the cellular protein, TMEM43, and HSV-1 genomes in LUHMES cells. Additionally, we find that knockdown of TMEM43 prior to infection results in a decreased ability of HSV-1 to establish latency. This work highlights a potential mechanism for how the LAT facilitates the establishment of HSV-1 latency in human neurons.
- 21 December 2023
- Published by American Society for Microbiology in Journal of Virology
- Vol. 97 (12) , e0143823
A viral lncRNA tethers HSV-1 genomes at the nuclear periphery to establish viral latency
Herpes simplex virus 1 (HSV-1) produces a long noncoding RNA, the latency-associated transcript (LAT), that mediates silencing of the virus in neurons through unknown mechanisms. Here, we show that the LAT binds both the cellular transmembrane protein 43 (TMEM43) and HSV-1 genomes in human neurons. Additionally, loss of TMEM43 prior to infection results in a decreased ability of the virus to establish latency, mirroring phenotypes of LAT promoter mutant viruses which are also defective in establishing latency. These data support a unique mechanism whereby the LAT binds TMEM43 and the HSV genome to localize HSV-1 genomes to the nuclear periphery to repress lytic viral transcription and establish viral latency and suggests that TMEM43 may play a similar role in regulating cellular genes. IMPORTANCE: Herpes simplex virus 1 (HSV-1) establishes lifelong latency in neuronal cells. Following a stressor, the virus reactivates from latency, virus is shed at the periphery and recurrent disease can occur. During latency, the viral lncRNA termed the latency-associated transcript (LAT) is known to accumulate to high abundance. The LAT is known to impact many aspects of latency though the molecular events involved are not well understood. Here, we utilized a human neuronal cell line model of HSV latency and reactivation (LUHMES) to identify the molecular-binding partners of the LAT during latency. We found that the LAT binds to both the cellular protein, TMEM43, and HSV-1 genomes in LUHMES cells. Additionally, we find that knockdown of TMEM43 prior to infection results in a decreased ability of HSV-1 to establish latency. This work highlights a potential mechanism for how the LAT facilitates the establishment of HSV-1 latency in human neurons.
- 23 March 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (3) , e0040922
Closing the Brief Case: Bergeyella zoohelcum Bacteremia in an Immunocompromised 69-Year-Old Patient
- 23 March 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (3) , e0040922
Closing the Brief Case: Bergeyella zoohelcum Bacteremia in an Immunocompromised 69-Year-Old Patient
- 23 March 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (3) , e0040822
The Brief Case: Bergeyella zoohelcum Bacteremia in an Immunocompromised 69-Year-Old Patient
A 69-year-old male with a history of metastatic prostate cancer on chemotherapy and lymphedema of bilateral lower extremities presented to the emergency department (ED) in septic shock with confusion and weakness. The patient was hypotensive (blood pressure, 69/50 mm/Hg), tachycardic (heart rate, 110 beats per minute), and tachypneic (respiratory rate, 24 breaths per minute) upon presentation to the ED. On physical examination, erythema and tenderness were observed below the left knee to above the ankle, concerning for cellulitis. Computed tomography (CT) imaging of the left lower extremity revealed prominent thickening of the subcutaneous soft tissues but did not show loculated fluid collection, ulceration, or a sinus tract. The patient was admitted to the intensive care unit (ICU) for further care.
- 23 March 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (3) , e0040822
The Brief Case: Bergeyella zoohelcum Bacteremia in an Immunocompromised 69-Year-Old Patient
A 69-year-old male with a history of metastatic prostate cancer on chemotherapy and lymphedema of bilateral lower extremities presented to the emergency department (ED) in septic shock with confusion and weakness. The patient was hypotensive (blood pressure, 69/50 mm/Hg), tachycardic (heart rate, 110 beats per minute), and tachypneic (respiratory rate, 24 breaths per minute) upon presentation to the ED. On physical examination, erythema and tenderness were observed below the left knee to above the ankle, concerning for cellulitis. Computed tomography (CT) imaging of the left lower extremity revealed prominent thickening of the subcutaneous soft tissues but did not show loculated fluid collection, ulceration, or a sinus tract. The patient was admitted to the intensive care unit (ICU) for further care.
- 28 February 2023
- Published by American Society for Microbiology in Journal of Virology
- Vol. 97 (2) , e0193522
HSV-1 LAT Promoter Deletion Viruses Exhibit Strain-Specific and LAT-Dependent Epigenetic Regulation of Latent Viral Genomes in Human Neurons
Herpes simplex virus 1 (HSV-1) establishes a lifelong infection in neuronal cells. Periodically, the virus reactivates from this latent state and causes recurrent disease.
- 28 February 2023
- Published by American Society for Microbiology in Journal of Virology
- Vol. 97 (2) , e0193522
HSV-1 LAT Promoter Deletion Viruses Exhibit Strain-Specific and LAT-Dependent Epigenetic Regulation of Latent Viral Genomes in Human Neurons
Herpes simplex virus 1 (HSV-1) establishes a lifelong infection in neuronal cells. Periodically, the virus reactivates from this latent state and causes recurrent disease.
- Open Access
- 14 January 2023
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 48, 102654
Treatment of infection and inflammation associated with COVID-19, multi-drug resistant pneumonia and fungal sinusitis by nebulizing a nanosilver solution
- 14 January 2023
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 48, 102654
Open AccessTreatment of infection and inflammation associated with COVID-19, multi-drug resistant pneumonia and fungal sinusitis by nebulizing a nanosilver solution
- Open Access
The Impaired Neurodevelopment of Human Neural Rosettes in HSV-1-Infected Early Brain Organoids
Intrauterine infections during pregnancy by herpes simplex virus (HSV) can cause significant neurodevelopmental deficits in the unborn/newborn, but clinical studies of pathogenesis are challenging, and while animal models can model some aspects of disease, in vitro studies of human neural cells provide a critical platform for more mechanistic studies. We utilized a reductionist approach to model neurodevelopmental outcomes of HSV-1 infection of neural rosettes, which represent the in vitro equivalent of differentiating neural tubes. Specifically, we employed early-stage brain organoids (ES-organoids) composed of human induced pluripotent stem cells (hiPSCs)-derived neural rosettes to investigate aspects of the potential neuropathological effects induced by the HSV-1 infections on neurodevelopment. To allow for the long-term differentiation of ES-organoids, viral infections were performed in the presence of the antiviral drug acyclovir (ACV). Despite the antiviral treatment, HSV-1 infection caused organizational changes in neural rosettes, loss of structural integrity of infected ES-organoids, and neuronal alterations. The inability of ACV to prevent neurodegeneration was associated with the generation of ACV-resistant mutants during the interaction of HSV-1 with differentiating neural precursor cells (NPCs). This study models the effects of HSV-1 infection on the neuronal differentiation of NPCs and suggests that this environment may allow for accelerated development of ACV-resistance.
Open AccessThe Impaired Neurodevelopment of Human Neural Rosettes in HSV-1-Infected Early Brain Organoids
Intrauterine infections during pregnancy by herpes simplex virus (HSV) can cause significant neurodevelopmental deficits in the unborn/newborn, but clinical studies of pathogenesis are challenging, and while animal models can model some aspects of disease, in vitro studies of human neural cells provide a critical platform for more mechanistic studies. We utilized a reductionist approach to model neurodevelopmental outcomes of HSV-1 infection of neural rosettes, which represent the in vitro equivalent of differentiating neural tubes. Specifically, we employed early-stage brain organoids (ES-organoids) composed of human induced pluripotent stem cells (hiPSCs)-derived neural rosettes to investigate aspects of the potential neuropathological effects induced by the HSV-1 infections on neurodevelopment. To allow for the long-term differentiation of ES-organoids, viral infections were performed in the presence of the antiviral drug acyclovir (ACV). Despite the antiviral treatment, HSV-1 infection caused organizational changes in neural rosettes, loss of structural integrity of infected ES-organoids, and neuronal alterations. The inability of ACV to prevent neurodegeneration was associated with the generation of ACV-resistant mutants during the interaction of HSV-1 with differentiating neural precursor cells (NPCs). This study models the effects of HSV-1 infection on the neuronal differentiation of NPCs and suggests that this environment may allow for accelerated development of ACV-resistance.